SCHEMBL12123253

SCHEMBL12123253

Fc1ccc(-c2cc3cc4c(cc(-c5ccc(F)cc5)n4-c4ccc5c(c4)c4ccccc4n5-c4ccccc4)cc3n2-c2ccc3c(c2)c2ccccc2n3-c2ccccc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.45
▸ ATM Q13315 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ JAK2 O60674 1/20 0.40
▸ JAK3 P52333 1/20 0.40
▸ RAC2 P15153 1/20 0.37
▸ RAC3 P60763 1/20 0.37
▸ CDC42 P60953 1/20 0.37
▸ RAC1 P63000 1/20 0.37
▸ NR3C1 P04150 1/20 0.37
▸ PTGS2 P35354 2/20 0.36
▸ GRIA1 P42261 1/20 0.36
▸ CACNG8 Q8WXS5 1/20 0.36
▸ CACNG2 Q9Y698 1/20 0.36
▸ HAO1 Q9UJM8 1/20 0.36
▸ ALOX5 P09917 1/20 0.35
▸ PTGER4 P35408 1/20 0.35
▸ KMT2A Q03164 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12123237 0.92 KDM4E (0.44) KDM4EATML3MBTL1JAK2JAK3
SCHEMBL12123250 0.91 L3MBTL1 (0.49) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL12123245 0.91 L3MBTL1 (0.51) KDM4EATML3MBTL1JAK2JAK3
SCHEMBL12123384 0.89 KDM4E (0.39) KDM4EATML3MBTL1JAK2JAK3
SCHEMBL12123248 0.88 KDM4E (0.43) KDM4EATML3MBTL1JAK2JAK3
SCHEMBL12123355 0.88 KDM4E (0.38) KDM4EATML3MBTL1JAK2JAK3
SCHEMBL12123243 0.88 KDM4E (0.45) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL12123395 0.87 KDM4E (0.38) KDM4EATML3MBTL1JAK2JAK3
SCHEMBL12123387 0.87 KDM4E (0.38) KDM4EATML3MBTL1JAK2JAK3
SCHEMBL12123378 0.86 KDM4E (0.39) KDM4EATML3MBTL1JAK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8057920-B2 Heterocyclic compound and organic light emitting device comprising the same SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2011-11-15 — — US disclosed
US-8057920-B2 Heterocyclic compound and organic light emitting device comprising the same SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2011-11-15 — — US disclosed
US-20090146555-A1 Heterocyclic compound and organic light emitting device comprising the same SAMSUNG DISPLAY CO., LTD. (KR) 2009-06-11 — — US disclosed
US-20090146555-A1 Heterocyclic compound and organic light emitting device comprising the same SAMSUNG DISPLAY CO., LTD. (KR) 2009-06-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090146555-A1 Heterocyclic compound and organic light emitting device comprising the same TRPC1, TRPC3, TRPC4 KDM4E 4097/4885ATM 3666/4885L3MBTL1 2775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback